Aatmaj Healthcare Board of Directors
Get the latest insights into the leadership at Aatmaj Healthcare. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Dr. Tushar Karshanbhai Suvagiya | Managing Director |
| Mrs. Jignasa Tushar Suvagiya | Whole Time Director |
| Dr. Ravi Arvind Apte | Non Executive Director |
| Mr. Jignesh Harshvadan Gandhi | Independent Director |
| Mr. Niraj Bavanjibhai Lila | Independent Director |
| Dr. Mansukh Jivrajbhai Patel | Independent Director |
Aatmaj Healthcare Share price
AATMAJ
20.8
0.05 (0.24%)Last updated on 4 Nov, 2025 | 11:12 IST
BUYSELL
Today's High
20.80
Today's Low
20.80
52 Week Low
14.50
52 Week High
33.50
The current prices are delayed, login to your account for live prices
LoginAatmaj Healthcare FAQs
The board at Aatmaj Healthcare consists of experienced professionals, including Dr. Tushar Karshanbhai Suvagiya , Mrs. Jignasa Tushar Suvagiya , and others, overseeing the company’s strategic and corporate governance.
Directors at Aatmaj Healthcare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Dr. Tushar Karshanbhai Suvagiya is the current chairman at Aatmaj Healthcare.
Executive directors at Aatmaj Healthcare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Aatmaj Healthcare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Aatmaj Healthcare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.